These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A young woman with a severe bilateral pneumonia as the presenting sign of an adrenal carcinoma. Chamuleau SA; Corssmit EP; Pereira AM; van de Berg BT; Siegert CE Neth J Med; 2008 Mar; 66(3):121-4. PubMed ID: 18349468 [TBL] [Abstract][Full Text] [Related]
3. [Mitotane in the treatment of adrenal carcinoma]. Sane T Duodecim; 2010; 126(17):2040-6. PubMed ID: 21053521 [TBL] [Abstract][Full Text] [Related]
4. Adrenal gland: Cancer target of mitotane identified. Holmes D Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26370730 [No Abstract] [Full Text] [Related]
6. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog. Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004 [TBL] [Abstract][Full Text] [Related]
11. Management of adjuvant mitotane therapy following resection of adrenal cancer. Terzolo M; Ardito A; Zaggia B; Laino F; Germano A; De Francia S; Daffara F; Berruti A Endocrine; 2012 Dec; 42(3):521-5. PubMed ID: 22706605 [TBL] [Abstract][Full Text] [Related]
12. Adrenal cortical carcinoma: a case report. Judy JC; Scardino PL J Med Assoc Ga; 1973 Nov; 62(11):377-9. PubMed ID: 4128251 [No Abstract] [Full Text] [Related]
13. [Malignant adrenal carcinoma with metastases: exeresis and treatment with op'DD followed by cure]. Rappaport R; Schweisguth O; Cachin O; Pellerin D Arch Fr Pediatr; 1978 May; 35(5):551-4. PubMed ID: 678033 [TBL] [Abstract][Full Text] [Related]
14. Long QT syndrome under mitotane therapy. Pliquett RU; Eichfeld U; Stumvoll M; Koch CA J Endocrinol Invest; 2007 Feb; 30(2):167-8. PubMed ID: 17392609 [No Abstract] [Full Text] [Related]
15. Adjuvant mitotane in adrenocortical carcinoma. Dickstein G; Shechner C; Nativ O N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838 [No Abstract] [Full Text] [Related]
16. Adjuvant mitotane in adrenocortical carcinoma. Lee JE N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836 [No Abstract] [Full Text] [Related]
17. [Normalisation of contralateral adrenal function after long-term mitotane therapy in a girl after surgical treatment of adrenocortical carcinoma]. Lecka A; Ginalska-Malinowska M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):234-6. PubMed ID: 17020662 [TBL] [Abstract][Full Text] [Related]
18. [Research to find new treatments for ferrets with adrenal gland tumors]. Schoemaker N; Kuijten A Tijdschr Diergeneeskd; 2004 Nov; 129(21):722. PubMed ID: 15559397 [No Abstract] [Full Text] [Related]
19. Mitotane (o,p'-DDD) administration raises the serum level of high density lipoprotein (HDL) in normotriglyceridemia. Gebhardt DO; Moolenaar AJ; van Seters AP Horm Metab Res; 1993 Apr; 25(4):240-1. PubMed ID: 8514247 [No Abstract] [Full Text] [Related]
20. Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M Endocr Relat Cancer; 2008 Dec; 15(4):1043-53. PubMed ID: 18824557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]